Cytomark Ltd, as the owner of the IP and worldwide distribution rights for TransFix, is no longer operating and everything is now being transferred to Caltag Medsystems Ltd. Caltag is already the legal manufacturer of TransFix and now takes on full responsibility for marketing and distribution of the Cytomark products. This minor reorganisation allows us to really focus on the core brands of Caltag and TransFix.
International customers will still purchase through your normal local distributor, and the distributor will now place orders to Caltag instead of Cytomark. Nothing changes for our UK and Ireland customers who already purchase through Caltag.
Don’t Panic. Nothing has changed with our signature product TransFix. It is still being manufactured by the same people at Caltag, in the same way, and to the same standard.
The changes will be implemented over the next few weeks so look out for notices on new payments details, and for changes to the branding in our correspondence, marketing information and on the website.
Best wishes from everyone at Caltag,
Dean Coupar – Managing Director
